Format

Send to

Choose Destination
Nat Chem Biol. 2014 Oct;10(10):837-44. doi: 10.1038/nchembio.1613. Epub 2014 Aug 24.

A microbial biomanufacturing platform for natural and semisynthetic opioids.

Author information

1
Department of Bioengineering, Stanford University, Stanford, California, USA.
2
Department of Chemistry, Stanford University, Stanford, California, USA.

Abstract

Opiates and related molecules are medically essential, but their production via field cultivation of opium poppy Papaver somniferum leads to supply inefficiencies and insecurity. As an alternative production strategy, we developed baker's yeast Saccharomyces cerevisiae as a microbial host for the transformation of opiates. Yeast strains engineered to express heterologous genes from P. somniferum and bacterium Pseudomonas putida M10 convert thebaine to codeine, morphine, hydromorphone, hydrocodone and oxycodone. We discovered a new biosynthetic branch to neopine and neomorphine, which diverted pathway flux from morphine and other target products. We optimized strain titer and specificity by titrating gene copy number, enhancing cosubstrate supply, applying a spatial engineering strategy and performing high-density fermentation, which resulted in total opioid titers up to 131 mg/l. This work is an important step toward total biosynthesis of valuable benzylisoquinoline alkaloid drug molecules and demonstrates the potential for developing a sustainable and secure yeast biomanufacturing platform for opioids.

PMID:
25151135
PMCID:
PMC4167936
DOI:
10.1038/nchembio.1613
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center